We provide a diverse range of ligands tailored for immunopharmacology research, facilitating studies of immune system modulation and therapeutic development. These meticulously curated ligands target various immune receptors, cytokines, and signaling pathways, enabling investigations into immune responses, inflammation, and autoimmune diseases. Rigorously characterized for potency and specificity, our selection includes small molecules, antibodies, and cytokines, among others, crucial for elucidating immunological mechanisms and developing novel immunotherapies. Whether investigating immune cell activation, cytokine signaling, or immunomodulatory pathways, our ligands empower researchers to advance immunopharmacology research and address unmet medical needs in immune-related disorders.
Ligands of Immunopharmacology
GSK2126458 (GSK458), Inhibitor of mechanistic target of rapamycin kinase;Inhibitor of phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit alpha;Inhibitor of phosphatidylinositol-4;5-bisphosphate 3-kinase catalytic subunit beta;Inhibitor of phosphatidylinositol-4;Cas#:1086062-66-9
Starting at $34.90
GSK 583, Inhibitor of receptor interacting serine/threonine kinase 2Cas#:1346547-00-9
Starting at $165.90
-
-
-
-
-
-
- Rapamycin (DMSO solution), Inhibitor of FKBP prolyl isomerase 1A
Cas#:53123-88-9
Starting at $660.90
